ConductScience.org, home

Paper8096582

Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.

Aboulker JP and 1 other. Lancet, 1993. Cited by 221 papers, by iCite.

Cite this record

ConductScience Library. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Papers, record 8096582. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096582

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.
PubMed
Journal
Lancet
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Letter, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
221
iCite
Relative citation ratio, by iCite
7.12
iCite
Revised in PubMed
2019-06-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aboulker JPJ P
2Swart AMA M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related ComplexMajor topic
Acquired Immunodeficiency SyndromeMajor topic
ZidovudineMajor topic
CD4-Positive T-Lymphocytes
Double-Blind Method
Female
Follow-Up Studies
Humans
Leukocyte Count
Male

Source PubMed

Download CSV of topics

Comments and corrections6

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8096900Immediate versus deferred zidovudine.https://conductscience.org/library/papers/8096900PubMed
Comment in8096901Immediate versus deferred zidovudine.https://conductscience.org/library/papers/8096901PubMed
Comment in8098407The Concorde trial.https://conductscience.org/library/papers/8098407PubMed
Comment in8098408The Concorde trial.https://conductscience.org/library/papers/8098408PubMed
Comment in8098409The Concorde trial.https://conductscience.org/library/papers/8098409PubMed
Comment in8098411The Concorde trial.https://conductscience.org/library/papers/8098411PubMed

Download CSV of comments and corrections

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.

PMIDTitleJournalYearIn PapersSource
42841414Pediatric NIH Workshop: Session I: Nonhuman Primate Models in HIV Prevention Research-A Historical and Comparative Perspective.J Med Primatol2026https://conductscience.org/library/papers/42841414PubMed
33920955Antiretroviral Drugs Impact Autophagy with Toxic Outcomes.Cells2021https://conductscience.org/library/papers/33920955PubMed
32885188Optimizing the development and evaluation of complex interventions: lessons learned from the BetterBirth Program and associated trial.Implement Sci Commun2020https://conductscience.org/library/papers/32885188PubMed
25151563Antiretroviral therapy: when to start.Infect Dis Clin North Am2014https://conductscience.org/library/papers/25151563PubMed
19390940Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.Int J Clin Oncol2009https://conductscience.org/library/papers/19390940PubMed
18373700Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.Clin Exp Immunol2008https://conductscience.org/library/papers/18373700PubMed
10448336Changing patterns of HIV related ocular disease.Sex Transm Infect1999https://conductscience.org/library/papers/10448336PubMed
10163412Current controversies in the treatment of HIV infection and AIDS. An economic perspective.Pharmacoeconomics1996https://conductscience.org/library/papers/10163412PubMed
10155284Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries.Pharmacoeconomics1994https://conductscience.org/library/papers/10155284PubMed
9584550The Medication Attribution Scale: perceived effects of antiretrovirals and quality of life.Qual Life Res1998https://conductscience.org/library/papers/9584550PubMed
9517872Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.Eur J Epidemiol1998https://conductscience.org/library/papers/9517872PubMed
9449274Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9449274PubMed
9049580The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.Eur J Clin Pharmacol1997https://conductscience.org/library/papers/9049580PubMed
9041402Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing.J Clin Microbiol1997https://conductscience.org/library/papers/9041402PubMed
9021201Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9021201PubMed
8940441Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.J Clin Microbiol1996https://conductscience.org/library/papers/8940441PubMed
8761234How can impact factors be improved?BMJ1996https://conductscience.org/library/papers/8761234PubMed
8727875Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.J Clin Microbiol1996https://conductscience.org/library/papers/8727875PubMed
8655161Ups and downs--and ups in the antiviral therapy of HIV infection.Genitourin Med1996https://conductscience.org/library/papers/8655161PubMed
8583491Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users.J Natl Med Assoc1996https://conductscience.org/library/papers/8583491PubMed

See all 46 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8096582

GET https://conductscience.org/api/papers/v1/8096582/cited_by?page=2